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Solid state NMRFibrillation of β amyloid (Aβ) peptides and the accumulation of amyloid plaques are considered as an important
clinical hallmark to identify Alzheimer's disease (AD). The physiological connection between Aβ plaques and the
disruption of neuronal cells has not been clearly understood. One hypothesis to explain the Aβ neurotoxicity is
that the ﬁbrillation process induces disruption to the cellular membrane. We studied the Aβ ﬁbrillation process
in two biologically relevant conditions with the peptide either pre-incorporated into or externally added to the
synthetic phospholipid bilayers. These two sample preparation conditions mimic the physiological membrane
proximities of Aβ peptides before and after the enzymatic cleavage of amyloid precursor protein (APP). Using
thioﬂavin T (ThT) ﬂuorescence and transmission electronmicroscopy (TEM), wewere able to monitor the kinet-
ics and morphological evolution of ﬁbril formation, which was highly sensitive to the two sample preparation
protocols.While the external addition protocol generates long andmatureﬁbrils throughnormal ﬁbrillation pro-
cess, the pre-incubation protocol was found to stabilize the immature protoﬁbrils. Fluorescence spectroscopy
studies with doubly-labeled phospholipids indicated that there may be a lipid uptake process associated with
the ﬁbril formation. Solid state nuclear magnetic resonance (NMR) spectroscopy provided evidence for high
resolution structural variations in ﬁbrils formed with different protocols, and in particular the stabilization of
long-range contact between N- and C-terminal β strands. In addition, disruption of phospholipid bilayers was
supportedbymeasurementswith 31P chemical shifts and relaxation time constants. This article is part of a Special
Issue entitled: NMR Spectroscopy for Atomistic Views of Biomembranes and Cell Surfaces. Guest Editors: Lynette
Cegelski and David P. Weliky.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
One of the most crucial clinical hallmarks for the diagnosis of
Alzheimer's disease (AD) is the accumulation of extracellular β amyloid
(Aβ) plaques around neuronal cells [1,2]. The elementary building blocks
of these plaques are Aβ ﬁbrils, which come from the aggregation of Aβ
peptides [3,4]. These peptides are 40- or 42-residue segments generated
from enzymatic cleavage of large membrane-associated amyloid precur-
sor protein (APP) [5,6]. Previous liquid state nuclear magnetic resonance
(NMR) spectroscopy study on the trans-membrane domain of APP has
shown that the Aβ sequencewas located at the interior of themembrane
bilayer [7]. After cleavage, the peptide should be partially inserted in the
membrane and could be eluted from themembrane bilayer. Themolecu-
lar mechanisms and the trigger of Aβ elution are not fully understood,
however, the total amount of cholesterol as well as cholesterol distribu-
tion across themembrane bilayer had been considered to have importantctroscopy for Atomistic Views of
egelski and David P. Weliky.
, Binghamton University, 4400
+1 607 777 2298.effects [8]. Aggregation of Aβwhich leads to theﬁbril formationmay start
after the peptide elution, and the ﬁbrillation process may induce disrup-
tion to the membrane bilayer. This has been proposed as one molecular
mechanism for Aβ neurotoxicity [8–11].
Previous experiments have demonstrated that Aβ interacts with ar-
tiﬁcial membrane bilayers, isolated brain membranes as well as plasma
membranes in living cells [12–23]. For synthetic membrane with phos-
pholipids, it has been shown that the binding of Aβ can be affected by
both the primary peptide sequence and the ﬂuidity and phase of the
membrane [12,14,15,24]. Short segments of the peptide with the most
hydrophobic part of the primary sequence aremore likely to be inserted
into the membrane hydrophobic core [12]. The full-length peptides
with chargedN-terminus could interact with the polar lipid headgroups
through electrostatic interactions. Binding of Aβ to syntheticmembrane
monolayers results in reduced membrane ﬂuidity, probably by forming
immobile domains which contained phospholipids and short ﬁbrillar
fragments [15]. Conformational change in Aβ upon membrane binding
has been monitored using circular dichroism (CD) spectroscopy. It has
been shown that the peptide's global secondary structure remains to
be random coil if the phospholipid headgroups are neutral. However,
regular secondary structures form upon the addition of negatively
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served at intermediate peptide to lipid (P:L) molar ratio (i.e. b1:50),
while the fraction of α-helical conformation increases with lower P:L
[16]. Solid state NMR spectroscopy has been applied as a unique ap-
proach to obtainmolecular-level information on themembrane interac-
tions of amyloid proteins and antimicrobial peptides [25–27], mainly
because the system is naturally non-crystalline and insoluble. The 13C
chemical shift measurements on the short segment Aβ29–42 have
shown a predominant β strand conformation upon binding with P:L
that equals to 1:30 [28]. Deuterium NMR has also provided evidence
that the methyl group of Ala33 in Aβ29–42 G33A mutant interacts with
the membrane bilayer. In addition, the 31P transverse relaxation (T2)
time constant analysis has indicated that the peptides were more likely
to interact with the negatively charged phosphatidylserine (PS), rather
than the neutral phosphatidylcholine (PC) [29].
There is also a large degree of variation in terms of both the peptide
locations in membrane bilayers and the change of membrane ﬂuidity
when the Aβ is added to isolated brain membranes. The initial binding
of the peptide to human plasma membrane surface has been observed
using electron microscopy (EM) [17]. Using rat synaptic plasma mem-
brane, it has been shown that the soluble Aβ1–40 incorporated into the
hydrophobic interior and the non-soluble aggregates had close proxim-
ity to the polar headgroup regions, presumably because it was difﬁcult
for the aggregates to travel through the membrane. The effect of Aβ
on membrane ﬂuidity has not been clearly demonstrated. Some of the
previous work have shown that the ﬂuidity of human hippocampal
membranes was greatly reduced by the addition of full-length, neuro-
toxic Aβ1–40 or Aβ1–42, but was not affected with shorter, non-toxic
Aβ1–29 [20,21,23]. However, there are also reports on the increase of
Aβ disorders and membrane ﬂuidity upon interaction [19,30,31]. For
the plasma membrane in living cells, it has been recently shown that
the membrane ﬂuidity was signiﬁcantly reduced by oligomeric Aβ spe-
cies comparing with ﬁbrillar or monomeric species [22].
Due to the complexity of the Aβ–membrane system, the molecular
mechanism of interactions is not well understood, which includes the
structural evolution of Aβ from monomeric peptides to ﬁbrillar species
and the molecular-level membrane disruption during the ﬁbrillation
process. In vitro models for studying these molecular mechanisms
involve synthetic membrane bilayer with phospholipids. Unlike func-
tional proteins, Aβ ﬁbrils do not have a naturally folded state with
global minimum energy. The ﬁbril structures are proved to be very sen-
sitive to external environment, particularly the sample preparation
conditions [32–39]. In addition, the elution of Aβ after cleavage may
not be the only fate for this peptide. Since it could be inserted into
themembrane interior asmonomer, it could also be involved in the for-
mation of endosomes [12,19]. For these reasons, we hope to study the
Aβ structure in the presence ofmembrane aswell as themembrane dis-
ruption using in vitro models in a more systematic way. We prepared
Aβ/membrane samples using two different protocols. The “external
addition” protocol addedmonomeric Aβ peptides into preformed phos-
pholipid membranes, which mimic the scenario where there was an
extracellular aggregation process. The “pre-incorporation” procedure,
on the other hand, generated phospholipid vesicles with Aβ embedded
beforehand. This procedure may simulate the case where there is
membrane-bound Aβ. The latter case could also happen when there is
a formation of cholesterol-enriched lipid domains, which tends to in-
crease the local concentration of Aβ [18,40]. Effects of sample prepara-
tion on peptide conformation and membrane interactions have been
noticed previously. It has been shown by CD spectroscopy that the
“pre-incorporation” procedure stabilizes the global α-helix conforma-
tion of Aβwithin a time period of several weeks, while for the “external
addition” samples, the peptides experienced a conformational conver-
sion from random coil to β sheet within two weeks [41]. In addition,
static solid state NMR 31P spectroscopy has suggested that the “pre-
incorporation” procedure induced an increased intensity of isotropic
peak, which means disruption of the bilayer structures and formationof small spherical lipid construct like micelles. The external addition of
Aβ does not change the membrane global structure [29].
To start answering the question of the molecular mechanisms of
membrane disruption induced by Aβ ﬁbrillation, it is crucial to monitor
the membrane disruption effect in the same time course as the ﬁbrilla-
tion process. Previous work on the islet amyloid polypeptide (IAPP) uti-
lizes synchronized ﬂuorescence measurements for both ﬁbrillation and
leakage of membrane contents [42]. In addition, it has been shown that
the detailed phospholipid compositions might have signiﬁcant effects
on the aggregation of amyloid proteins, presumably due to the change
inmembrane curvature [43]. In this presentwork, we utilized thioﬂavin
T (ThT) ﬂuorescence spectroscopy tomonitor the ﬁbril formation kinet-
ics, and double-ﬂuorophore-labeled phospholipids to study the mem-
brane disruption effect. The later approach has been widely used to
study the membrane fusion kinetics. Meanwhile, transmission electron
microscopy (TEM)was applied in a time-synchronized fashion to follow
the morphological evolution of the Aβ ﬁbrillation process. Solid state
NMR spectroscopy was used to study the molecular-level structural
difference of Aβ ﬁbrils from different sample preparation conditions,
as well as the change in membrane structures.
2. Materials and methods
2.1. Peptide synthesis
Unlabeled Aβ1–40 for ﬂuorescence and TEM studies, and Aβ1–40 with
13C, 15N-uniform labeling at residues Phe19 and Leu34 for NMR studies,
were both synthesized on solid phase peptide synthesizer (Applied
Biosystems Inc., Foster City, CA) with standard Fmoc chemistry. The pep-
tide was then cleaved from supported resin using triﬂuoroacetic acid
(TFA) cleavage mixture (TFA/phenol/water/thioanisole/EDT, 82.5/5/5/5/
2.5) and puriﬁed using high performance liquid chromatography (HPLC,
Beckman-Coulter Inc., Brea, CA) with reversed-phase C18 column. The
purity of both peptides was proved to be N95% using matrix-assisted
laser desorption ionization (MALDI) time-of-ﬂight (TOF) mass spectrom-
eter (Shimadzu Scientiﬁc Instrument Inc., Columbia, MD).
2.2. Liposome preparation
In both “pre-incorporation” and “external addition” protocols, the
molar ratio of P:L equals 1:20. Four different types of lipid mixtures
were utilized for each sample preparation method with different
fractions of negatively charged headgroups and/or the content of
cholesterol. The lipid mixtures were: 100% 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC, from Avanti Polar Lipids Inc.,
Alabaster, AL); 80% POPC plus 20% 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-(1′-rac-glycerol) (POPG); 80% POPC, 20% POPGplus additional
30 mol% cholesterol (CH); and total brain extract. These samples were
named as PC, PC/PG, PC/PG/CH and BR hereafter. The negatively charged
phospholipids have been reported to increase the Aβ absorption to the
liposome [29]. Cholesterol has been proposed as an important compo-
nent involving Aβ binding as well as membrane elution [7,18,40]. In
addition, the brain extract was utilized tomimic themembrane compo-
sition in vivo. For “pre-incorporation” samples, the designed amounts of
lyophilized Aβ1–40 peptide and phospholipid mixtures were co-
dissolved in hexaﬂuoro-2-propanol (HFIP). The solution was sonicated
in a water bath for 5 min to ensure the complete dissolving and then
the solvent was removed with N2 ﬂow. The remaining lipid/peptide
ﬁlm was dried in a desiccator overnight and rehydrated using 10 mM
phosphate buffer (pH 7.4, containing 0.01% NaN3). Peptide concentra-
tion was kept at 25 μM to avoid the formation of large aggregation dur-
ing the time period of vesicle preparation. Re-suspended lipid/peptide
mixturewas agitated vigorously for 1 h at ambient temperature. The so-
lution containing mainly multilamellar vesicles (MLVs) was then incu-
bated at 37 °C for ﬁbrillation. For “external addition” samples, all MLVs
were pre-formed using the same protocols as provided above without
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(DMSO) anddiluted into vesicle solutions so that theﬁnal concentration
of peptide was 25 μM. There was ~1% (v/v) DMSO in the ﬁnal MLV
solution.
2.3. Fluorescence spectroscopy
For the ﬁbrillation kinetics measurements using ThT, a 10 μL aliquot
of Aβ/vesicle solutionwas added into 100 μL of 10mMThT solution, and
the ﬂuorescence emission was recorded at 490 nm with excitation
wavelength of 423 nm. The sample aliquots were taken from Aβ ﬁbril-
lation solution at different time points for both “pre-incorporation” and
“external addition” samples. Control experiments were done with
MLVs formed using the same lipid mixtures without peptides.
For the measurements to identify membrane disruption,
2 mol% of ﬂuorophore-labeled lipids, 1,2-dipalmitoyl-sn-glycero-
3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD-
PE) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-
(lissamine rhodamine B sulfonyl) (Rh-PE), were incorporated into the
total lipid mixtures. These double-ﬂuorophore-labeled vesicles have
been previously utilized to study themembrane fusion process induced
by the human immunodeﬁciency virus (HIV) fusion peptides [44,45].
Excitation of the NBD ﬂuorophore at ~470 nm results in an emission
at ~535 nm, which overlaps with the excitation wavelength of Rh
ﬂuorophore. The induced ﬂuorescence emission at ~585 nm was de-
tected and the change of emission intensity was related to the proxim-
ity between two ﬂuorophore groups. Each assay contained 90% of
unlabeled vesicles and 10% of double-ﬂuorophore-labeled vesicles. An
aliquot of 100 μL Aβ/membrane solution was taken out for measure-
ment at the time points determined by ﬁbrillation. Control experiments
without peptides were done to calibrate the effect of spontaneous lipid
mixing. Both types of ﬂuorescence measurements were conducted on
ﬂuorimeter (StellarNet Inc., Tampa, FL) with single wavelength diode
light sources. The emission signal was collected with 1000 ms signal
averaging.
2.4. Transmission electron microscopy
All negatively-stained TEMmeasurements were completed on a FEI
Morgagni Electron Microscope. An aliquot of 10 μL Aβ/membrane solu-
tion was deposited on a TEM sample grid (Ted Pella Inc., Redding, CA)
coated with a thin layer of carbon ﬁlm for 2 min. The solution was blot-
ted and then the grid was washed once with 10 μL deionized water.
After removing the water, the grid was stained with 10 μL of 3% uranyl
acetate for 35 s and subject to measurements.
2.5. Solid state NMR
Fibrils were allowed to grow for at least 2 weeks before the samples
were collected. TEM images were recorded to verify that there was no
further morphological evolution of ﬁbrils at the time point of sample
collection. For NMR sample preparation, Aβ/membrane solution
was pelleted down with ultracentrifugation at 432,000 ×g (Beckman
Coulter Inc., Brea, CA) for 1 h at 4 °C. The wet pellet was frozen and
transferred into magic angle spinning (MAS) solid state NMR rotor
without lyophilization to avoid any disruption of membrane structure
due to the dehydration process.
Two-dimensional (2D) 13C/13C spin diffusion experimentswere per-
formed on a 9.4 T Varian (Agilent Technologies Inc., Santa Clara, CA)
solid state NMR spectrometer with a 3.2 mm HXY triple resonance
magic angle spinning (MAS) probe. Spectrawere collectedwith 1.5 s re-
cycle delay, 500 ms radiation assisted diffusion (RAD) period, 10.0 kHz
MAS frequency, 50 kHz 13C cross polarization (CP) ﬁeld with linear
ramp and ~100 kHz 1H decoupling ﬁeld. All NMR experiments
were done with−10 °C cooling air to prevent dehydration, and the ac-
tual sample temperature was ~20 °C. The sample temperature anddehydration levels were veriﬁed by detecting the 1H chemical shifts
and signal intensities before and after experiments. All 2D spectra were
processed with 150 Hz Gaussian line broadening in both dimensions.
The static and MAS 31P spectra were collected on a 14.1 T Bruker
(Bruker Biospin Corp., Billerica, MA) NMR spectrometer equipped
with a 2.5 mm TriGamma MAS probe. Similar to the 13C experiments,
samples were protected from dehydration throughout the experiment
using cooling air. The static 31P experiments were donewithout sample
spinning and the 31P T2 relaxationmeasurements were completed with
Hahn Echo pulse sequence (90°-τ–180°-echo) with 50 kHz radiofre-
quency (rf) pulses and 100 kHz 1H decoupling. Each 31P spectrum was
acquired with 64 scans and processed with 20 Hz Gaussian line broad-
ening. Samples were spinning at 10.0 kHz for all measurements. All
spectra were referenced to the 31P chemical shift of 80% H3PO4 at
0.0 ppm. Experimental datawere ﬁt to a single exponential decay curve.
3. Results
3.1. Morphological evolution of Aβ ﬁbrils in different sample preparations
Fig. 1 showed the evolution of Aβmorphology along with the ﬁbril-
lation process. Typically in similar process without the membrane, the
peptide will experience certain lag period when nucleation happens
[46,47]. Small Aβ aggregates may form during the lag period, however
their presence may not be detected using TEM. As had been previously
demonstrated, at the experimental Aβ concentration, i.e. 25 μM, the ﬁ-
brillation process will not be detectable using TEM within at least 4 h
in the absence of membranes [48]. Fig. 1A–E showed the time-
evolution of sample morphology for the “pre-incorporation” samples,
and it was clear that curvy and short ﬁbrillar species were observed
even at the very beginning stage of ﬁbrillation process, i.e. 4 h. Although
the ﬁbril length increases over time, the curvy morphology, which is
typically for protoﬁbrils, did not have signiﬁcant change for samples in-
cubated up to 2 weeks. Meanwhile, the morphology of vesicles seemed
to be affected from the beginning of ﬁbrillation, where disintegration of
membranes was observed. For “external addition” samples, on the other
hand, formation ofﬁbrilswas not detected until incubation for 46 h.Ma-
ture ﬁbrils with long-ﬁlament-like morphology were observed from 69
to 93 h. It also seems that the detailed ﬁbrillation kinetics was affected
by the phospholipid components of LMVs. For LMVs with total PC/PG/
CH andBR, a clearmorphological evolution pathwaywasobserved. Dur-
ing the process, small oligomers in spherical shape were ﬁrst observed
around membrane surface. These spherical species were converted
into curvy protoﬁbrils which gradually made connection between vesi-
cles (Fig. 1H), and ﬁnally the curvy morphology changed into straight
and long. For LMVswith PC and PC/PG, such pathwaywas not observed,
and linear ﬁlaments were directly observed after approximately 70-
hour incubation (Fig. S1). This difference suggested that ﬁbril forma-
tion kinetics was affected by the membrane composition, presum-
ably related to the change in local concentration of Aβ. This was
consistent with previous observation in human cortex membranes
that Aβ aggregates were concentrated in membrane regions with
large cholesterol content [18]. However, this does not necessarily
mean that the presence of cholesterol accelerated the nucleation. In
fact in all cases, nucleation, which was deﬁned by the increase in
ThT ﬂuorescence intensities, started immediately after the addition
of peptides into vesicle solutions.
Theﬁnalmorphologies of both LMVs andAβﬁbrilswere different for
the two sample preparation approaches, but were similar for different
lipid mixtures within one sample preparation protocol. The “external
addition” ﬁbrils were long and straight, typically in length of several mi-
crons. The “pre-incorporation” ﬁbrils only extended to several hundreds
of nanometers within two weeks and the morphology remains curvy.
Themorphological feature of “pre-incorporation” ﬁbrils was very similar
to a previously observed metastable intermediate formed by the Iowa
mutant of Aβ. It was possible that the curvy ﬁlaments in the present
Fig. 1.Morphological evolution of Aβ/membrane systems prepared with (A–E) “pre-
incorporation” and (F–J) “external addition” sample preparation protocols using vesicles
with lipid mixture PC/PG/CH. TEM images were taken at (A and F) 4 h, (B and G) 22 h,
(C and H) 46 h, (D and I) 69 h and (E and J) 93 h after the initiation of ﬁbrillation. Arrows
in panel A indicated the formation of curvy ﬁlaments at the early stage of “pre-incorpora-
tion” protocol, and arrows in panel H showed the ﬁbril that connects two vesicles. The
scale bars were 100 nm in all images.
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shown that the presence of membrane would induce fragmentation of
mature lipids and the stabilization of short segments [15], which might
explain the maintaining of curvy morphology in “pre-incorporation”
samples. In addition, there was also difference in terms of the mem-
brane morphology. Predominant spherical vesicles were observed
throughout the ﬁbrillation process in “external addition” samples,
while disintegrated membrane fractions were detected at the very be-
ginning stage of “pre-incorporation” sample preparation (Fig. 1A).
3.2. Fibrillation kinetics was distinct for different protocols
ThT ﬂuorescence was recorded at different time points during the
ﬁbrillation process, and the plots shown in Fig. 2 were calibrated by
subtracting the ﬂuorescence of vesicle solutions without peptides at
the same time points. For the control sample, we observed very little
change of ﬂuorescence intensity as a function of incubation time, how-
ever the absolute values of emission intensity were dependent on the
lipid mixture components (Fig. S2). The presence of PG greatly en-
hanced the ﬂuorescence emission, while the presence of cholesterol
seemed to induce the decrease of the ﬂuorescence intensity.
The overall ﬁbril growth kinetics varied dramatically for the two
sample preparation protocols. The “external addition” samples showed
slow increase within the ﬁrst 5 days of incubation, and a more rapid
ﬂuorescence enhancement after one week. The ﬂuorescence emission
signal leveled off for all four types of lipid mixtures after two weeks of
incubation. The “pre-incorporation” samples, on the other hand, had
rapid signal increasing at the beginning stage of ﬁbrillation (i.e. from 4
to 43 h) but quickly leveled off thereafter. There was little further
change inﬂuorescence intensities up to twoweeks. These results clearly
suggested different ﬁbrillation pathways for the two sample prepara-
tion protocols. Lag period without detectable ﬂuorescence signal was
not observed in either case, which was different for wild-type Aβ ﬁbril-
lation process without the membrane [49]. For the “external addition”
protocols, the initial slow increase of ThT ﬂuorescence may indicate a
complicated process including the absorption of Aβ to the membrane
surface, concentration of the peptide to form aggregates, and the
conformational evolution that led to further ﬁbril elongation. For the
“pre-incorporation” samples, small oligomeric states of Aβmight already
exist at the beginning of incubation, which means that the structural
transition for ﬁbril elongation may only happen within the pre-
formed oligomers, i.e. only re-arrangement of Aβ monomers was
involved. In this case, there might be no requirement for recruiting
monomers from extra-membrane solution to reach a critical concentra-
tion. However, after the formation of the appropriate peptide conforma-
tion, further elongation required sufﬁcient contact between the short
ﬁbril segments (i.e. seeds) and monomeric peptides. For “external
addition” samples, this was more straightforward because the seeds
were probably located on the membrane surface. However, the “pre-
incorporation” ﬁbril seedsmay be buried inmembrane bilayers or inter-
act with phospholipids, which made further elongation process more
difﬁcult. Certainmetastable structuresmay be stabilized simply because
the energy cost for breaking the existing interactions (presumably
between ﬁbrils and membranes) was larger.
The absolute values ofﬂuorescence emission intensities at equilibrium
were determined by subtle changes in high resolution structures of Aβ
ﬁbrils [35,50], andwere difﬁcult to interpret without knowledge of struc-
tures. However in general, it was clearly shown that ﬁbril structureswere
sensitive to phospholipid components, which suggested that for the
mechanism studies using in vitro models, it was important to consider
the lipid content change and to use biologically relevant lipid mixtures.
3.3. Membrane disruption occurred simultaneously with ﬁbrillation
To understand the membrane disruption kinetics and mecha-
nisms, we introduced two types of ﬂuorophore-labeled phospholipids,
Fig. 2. Detection of thioﬂavin T (ThT) ﬂuorescence emissions as the function ﬁbrillation time for Aβ/membrane systems with the phospholipid compositions of (A) PC, (B) PC/PG, (C) PC/
PG/CH and (D) BR. In each plot, circles and diamonds indicated the “pre-incorporation” and “external addition” sample preparation conditions, respectively.
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emission of Rh group through the Forster resonance energy transfer
(FRET) mechanism. The assay was designed to detect membrane fusion
process. Since the labeled LMVswere diluted into unlabeled vesicles, as
the fusion happens, the distance between two ﬂuorophores became
longer and the ﬂuorescence intensity at the emission wavelength of
Rh-PE (i.e. ~585 nm) would decrease. Fig. 3 showed the time course
of emission intensities for different samples at 585 nm. The plots were
corrected by subtracting the ﬂuorescence changes only due to the
vesicles using control samples, which were very little (Fig. S3). Surpris-
ingly, a general trend of signal increasing rather than decreasing was
detected for all samples. To exclude the possibility of membrane fusion,
we did another control experiment by adding 1% Triton directly into the
vesicle solution. The results (Fig. S4), with an increasing intensity at
530 nmand decreasing intensity at 585 nm, clearly indicated the occur-
rence ofmembrane fusion. Therefore, we concluded that theAβ1–40was
not fusogenic, which was different from the shorter segment Aβ29–42
that has been proposed previously [51].
Similar to the ﬁbrillation kinetics proﬁles, the membrane disruption
kinetics was also distinct for the “external addition” and “pre-incorpora-
tion” samples. More importantly, the time courses for the two sets of
ﬂuorescence measurements showed a synchronized fashion, i.e. the
build-up curves for “pre-incorporation” samples were much rapid com-
paring with the “external addition” samples. All “pre-incorporation”
curves leveled off at ~22 h, which corresponded to the rapid increase
of ThT ﬂuorescence signals during the same time period. On the con-
trary, increase of Rh-PE emission matched with the initial ThT signal,
but leveled off after ~100 h. In addition in both protocols, membrane
disruption started immediately with the ﬁbrillation process. The results
suggested that the process of Aβ initial aggregation leading to ﬁbrillar
seeds was probably crucial for membrane disruption. For the “external
addition” case, the Rh ﬂuorescence intensities leveled off during the
time period of rapid ThT ﬂuorescence enhancement (i.e. the time period
after ~100 h), meaning that the elongation of mature ﬁbrils might have
little effect on themembranes. It has been recognized that it was the Aβ
oligomers rather thanmature ﬁbrils that have shown highest neurotox-
icity [52,53]. The combination of ThT and Rh ﬂuorescence seemed tosuggest that there were certain structural conversions at the beginning
stage of ﬁbrillation which are responsible for themembrane disruption.
The observation of Rh ﬂuorescence increasing also provided hints
about the detailed mechanisms of membrane disruption. It has been
proposed that the ﬁbrillation process can uptake phospholipids from
membrane bilayers [54]. Leakage of phospholipids alongwith the initial
ﬁbrillation process provided a possible explanation for the observation
that the distance between Rh and NBD groups within one vesicle was
getting closer. Another possible explanation involves the formation of
cation-selective channels formed by membrane fragmentation, which
corresponds to the two-step membrane disruption mechanism
proposed previously [55,56]. The fragmentation may also reduce the
size of liposomes, and therefore decrease the proximities between
ﬂuorophore-labeled lipids. These possibilities will be investigated in
future studies.
3.4. High resolution structural variation in different ﬁbrils and membrane
disruption
Solid state NMR 2D 13C/13C spin diffusion experiments were
performed to understand the detailed structural difference between dif-
ferent sample conditions. The Aβ1–40 ﬁbrils were labeled with U-13C,
15N-Phe19 and Leu34. These two residues were chosen because they
were located in the hydrophobic core region of all previously published
ﬁbril structures and there was potential strong contact with resolved
NMR cross peaks between them [32,57–59]. Meanwhile, the chemical
shifts of Phe19 are sensitive to sample preparation conditions.
Fig. 4 showed the representative 2DNMR spectrawith the lipidmix-
tures PC/PG/CH and BR in vesicles. Two major differences were ob-
served. First of all, within the same membrane, the “external addition”
samples gave stronger long-range contact (i.e. the Phe19/Leu34
crosspeak) comparing with the “pre-incorporation” samples. The result
indicated that the “pre-incorporation” protocol generated ﬁbrils with
less well-ordered structures, and probably the contact between N- and
C-terminal β strands was not well stabilized. Since the two labeled res-
idues were located in the hydrophobic core inmature ﬁbrils, it was pos-
sible that the “pre-incorporation” ﬁbrils contained structures that have
Fig. 3.Detection of Rh-PEﬂuorescence emissions as the function of ﬁbrillation time using Aβmixingwith 2mol% doubly-ﬂuorophore-labeled vesicles. Different lipidmixture components
were shown as (A and B) PC, (C andD) PC/PG, (E and F) PC/PG/CH and (G andH) BR. The panels A, C, E andGwere for “external addition” samples and the panels B, D, F andHwere for “pre-
incorporation” samples.
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ages, where the “external addition” ﬁbrils were more mature. Second,
the Cα and Cβ chemical shifts of Phe19 changed between samples pre-
pared using the same protocol but with different membrane compo-
nents, but the chemical shifts for Leu34 were the same (Fig. 4A and B).
The difference in detailed structure may explain the variation in ThT
ﬂuorescence between samples, particularly because the ladder formed
by Phe19 aromatic ring along the ﬁbril axis was proposed as a binding
site for ThT molecule [60,61]. The 13C linewidths for the two sample
preparation protocols were very similar (Fig. 4E and F), despite of the
large difference in sample morphologies. For ﬁbril formed with the
membrane, it was observed that the 13C linewidths were narrower for
mature ﬁbrils comparing with protoﬁbrils [35,59]. There might be
extra broadening of linewidths due to the interaction between ﬁbrils
and membranes.31P static and MAS spectra provided additional information about
the membrane disruption due to different sample preparation proto-
cols. Our results showed that the 31P chemical shift anisotropy (CSA)
for the “external addition” samples was ~30% broader comparing with
the corresponding “pre-incorporation” samples (Fig. 5A–B). This was
consistent with a similar previous study using 42-residue Aβ ﬁbrils
[29]. In addition, the “pre-incorporation” protocol increased the fraction
of isotropic 31P peak in the powder pattern, which was an indication
for the formation of smaller vesicles with rapid tumbling. The MAS
spectra for the “external addition” PC sample resulted in a single peak
at ~−1.9 ppm, while the “pre-incorporation” PC sample contained an
additional minor peak at ~−0.8 ppm (Fig. 5C–D). This means that a
small fraction of phosphatidylcholine molecules were located in a dif-
ferent chemical environment other than the initial phospholipid vesi-
cles. This second chemical environment might be due to the formation
Fig. 4. Two-dimensional (2D) 13C/13C spin diffusion solid state NMR spectra for samples preparedwith (A and B) “external addition” protocols and (C and D) “pre-incorporation” protocols.
The represented spectra were shown for vesicles with (A and C) PC/PG/CH and (B and D) BR. Horizontal dotted lines were drawn across the chemical shift of Leu34 Cγ1 to highlight the
inter-residue crosspeaks between Leu34 and Phe19 in “external addition” samples. Corresponding one-dimensional slices were shown in panels E and F for PC/PG/CH and BR, respectively.
The green solid lines in panel A indicated the chemical shifts for Cα/Cβ crosspeaks for the two residues. The green dotted lines in panel B showed that there was a shift in Phe19 Cα/Cβ
crosspeak position, but not in Leu34.
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tion process, or the formation of peptide–lipid aggregates [29]. The
fact that this minor component only existed in “pre-incorporated”
sample may indicate that such sample preparation protocol had more
signiﬁcant disruption effects to membranes comparing with the
“external addition” protocols, presumably due to the higher local Aβ
concentration in membrane. The T2 relaxation time constants for
these two peaks were also distinct. While the relaxation constant for
the main peak remained at ~1.0 ms, the minor peak showed a much
slower decay constant at ~2.7 ms. The presence of two 31P populations
with distinct T2 time constants were observed for PC peak in other ves-
icle components such as PC/PG and PC/PG/CH (shown in Fig. S5). The
analysis for BR samples was not performed because of complexity of
lipid headgroup compositions. Since long T2 indicates higher mobility
of 31P lipid headgroup, this result again illustrated that a small popula-
tion of PC were involved in a construct with high mobility.
4. Discussion
4.1. In vitro models for studying neurotoxicity mechanisms
The aggregation process of Aβ peptides is directly related to themo-
lecular mechanisms of neurotoxicity, and particularly the membrane
disruption process. However, since the ﬁbrils are misfolded aggregates,
it is unlikely that there is a well-deﬁned folded state like other function-
al proteins. This means that the detailed structures can be very sensitive
to external environments during the ﬁbrillation process, which gives
extra difﬁculties formolecularmechanism studies using in vitromodels.
Based on our results, we emphasize that it is crucial to ﬁnd model sys-
tems that represent the biologically relevant conditions, because subtle
changes in high resolution structures of ﬁbrils can lead to dramatic dif-
ference inmacroscopic characteristic such as ThTbinding. A large part ofdiagnosis strategy for Alzheimer's disease relies on the ﬂuorescent sig-
nal intensities from certain agents binding to the Aβ ﬁbrils or plaques.
The results could be misleading if the detailed binding mechanisms is
not understood, especially when the amyloid plaques contain ﬁbrils
with multiple high resolution structures.
Our results also show that it is important to study themolecular de-
tails of membrane disruptionmechanisms as a function of time. Current
arguments about the relative neurotoxicity levels for different ﬁbrillar
species (i.e. monomers, oligomers, protoﬁbrils and mature ﬁbrils)
focus on the measurements of neurotoxicity levels at static states, and
the discrepancies were obvious. For instance, it was thought that the
mature ﬁbrils had lower toxicity comparing with oligomers/protoﬁbrils
if both of them were added directly into the cell culture [62–64]. How-
ever, when mature ﬁbrils were sonicated and broke into short pieces,
they had comparable toxicity level as protoﬁbrils [59,65]. Since sonicat-
ed ﬁbril seeds may still undergo structural evolution, we suspect that
the time evolution of structures, rather than the static states, could be
more important. In this work, we utilized three different approaches in-
cluding TEM, ThT ﬂuorescence and Rh ﬂuorescence to track the ﬁbrilla-
tion and membrane disruption process, and observed the potential
correlation between them. Particularly, the time courses of two types
of ﬂuorescence build-up curves that match with each other suggested
that the initial structural evolution of Aβmay induce the major mem-
brane disruption. For the “external addition” samples, this initial aggre-
gation process may include the absorption and concentration of Aβ on
the membrane surface, as well as the consequent structural change to
formﬁbril seeds. There have been reports on the conformational change
of Aβ from random coil to partiallyα-helix, andﬁnally becamepredom-
inantly β-sheet uponmembrane binding [41]. Such structural evolution
may change the molecular-level interaction between peptides and
membranes, i.e. different residuesmay be exposed tomembrane surface
at different peptide conformations. For the “pre-incubation” samples,
Fig. 5. The 31P static, MAS solid state NMR spectra and T2 relaxation measurements for the (A, C and E) “external addition” and (B, D and F) “pre-incorporation” samples with PC vesicles.
Squares and diamonds in panel F represented relaxation curved for the major and minor peaks in panel D, respectively. Experimental data were ﬁt to single exponential decay curves.
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Speciﬁc interaction between lipids and oligomers might exist to stabi-
lize such oligomers, and these interactions could be disrupted during
the ﬁbrillation process, which may further induce destabilization of
membrane integrity.
To deeply understand the molecular mechanisms, high resolution
techniques such as solid state NMR spectroscopy have to be involved.
Solid state NMR has been proved to be extremely successful in solving
the atomic-level structures of mature ﬁbrils [36]. On the other hand, it
is also a “low sensitivity” technique that is not suitable for tracking the
intermediate structures during the ﬁbrillation process. One possibility
is to freeze-capture these intermediates at appropriate time points
[66], which can be monitored using other complementary approaches
such as TEM. However, the potential problem is that the interested in-
termediate may only be a small fraction within a complicated mixture
with multiple structures, and it is difﬁcult to identify the minor peaks
from a mixture of NMR signals. Our results with ThT ﬂuorescence
indicated that at least for the “external addition” samples, there was a
slow process from the initial Aβ aggregation to the elongation ofmature
ﬁbril. This process was characterized by the slow increase of ThT ﬂuo-
rescence emission. This was also the time period that showed the
most rapid Rh ﬂuorescence enhancement, which was an indication of
membrane disruption. Since the ThT ﬂuorescence is sensitive to very
subtle structural variation, we propose that there may be a structuralevolution during the time period and it leads to the major membrane
disruption. After the initial conformational change, the elongation of
mature ﬁbril will take place and this seemed to have less effect on
membranes.
Fig. 6 showed an alternate approach to study the intermediate Aβ
structure and possible neurotoxic structural evolution. Using known
solid state NMR structures for the mature ﬁbril, it is possible to design
molecules that can bind and block the elongation pathway. For the sim-
plest scenario, if we assume that there is a competition between two
species. One of themhas faster nucleation rate, but the nucleus (i.e. ﬁbril
seeds) is not as stable as the other species. The blockingmolecule is de-
signed based on the later species' structure because this will be the one
to form mature ﬁbril. When the blocking agents were added to the ini-
tial ﬁbrillation system, it will selectively bind to any structural domain
that transforms to the more stable species. In other words, it will stabi-
lize the intermediate whichwill otherwise get converted. This is similar
to the usage of conformational-speciﬁc antibodies for the structural
studies of Aβ oligomers [67]. However, since the blocking agents were
designed from speciﬁc structural model, this approach could be more
selective and more suitable for study detailed structural evolution
rather than bulk change in morphology. It is also a potential approach
to study the structural evolution during the ﬁbrillation process because
of the use of the blocking agent, we should be able to capture the inter-
mediate that is actually on-pathway.
Fig. 6.Models for the Aβ ﬁbrillation in the presence of phospholipidmembrane bilayers in
the “external addition” protocols. The key stepsmay include (a) absorption and concentra-
tion of Aβ on membrane surface, (b) conformational conversion to the structure that is
more suitable for elongation, (c) formation of ﬁbril seeds and (d) chain elongation to
form mature ﬁbrils. An alternative pathway shows that if a structural-speciﬁc blocking
agent is added at the beginning stage ofﬁbrillation, therewill be (c′) blocking of structural
domains with elongation potentials and (d′) equilibrium shifting to the intermediate
structures.
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It remains a question how exactly membrane bilayers get disrupted
by Ab oligomers and ﬁbrils. There have been a number of different
mechanisms involved in the interactions between ﬁbrils and mem-
branes. First of all, the ﬁbrillation process may uptake phospholipids. It
has been previously reported that for the islet amyloid polypeptide
(IAPP) which is associated with type II diabetes, the ﬁbrillation process
was accompanied by the association of lipids onto the ﬁbrils [54]. Our
results here suggested that the association was more likely to happen
during the initial structural evolution stage rather than the elongation
stage. Particularly for the “pre-incorporation” ﬁbril, the association be-
tween lipids and peptides may tend to stabilize the non-ﬁbrillar or
protoﬁbril structures, and prevent the formation of mature ﬁlaments.
It has also proposed that there are formation of speciﬁc ionic channels
(i.e. Ca2+ ion channels) with Aβ oligomers. This hypothesis was sup-
ported by atomic force microscopy (AFM) observation on channel-like
morphology as well as the electrophysiological studies on the voltage
jump across synthetic membranes due to the Aβ incorporation [68].
Our results with “pre-incorporation” models did not exclude the possi-
bility for the formation of trans-membrane Aβ oligomers or Aβ ionic
channels. In fact, previousworkwith theAβ Ca2+ ion channel did utilize
the sample preparation approach similar to our protocol, butwith lower
P:L ratio. It was likely that the “pre-incorporation” system contained a
mixture of protoﬁbrils and membrane-bound oligomers.4.3. Aβ aggregation pathway in the presence of the membrane
In biological systems, Aβwas cleaved from larger APP in themiddle of
the membrane bilayer, and the hydrophobic C-terminus of the Aβ se-
quencewas partially inserted into the bilayer interior right after the cleav-
age. The peptide segment could be eluted from the membrane and enter
the extracellular ﬂuid immediately because the charged C-terminus
would not be preferred in the hydrophobic center. Aβ aggregates may
be cleaned by the mechanism of autophagy, and autophagy deﬁciency
has been shown to associate with the increase of extracellular amyloid
plaque burden [69]. The peptide segment could also be involved in the
formation of endosomes [12,19], where presumably a trans-membrane
conﬁguration will be adopted. Since there might be multiple fates for
the Aβ segments right after cleavage, it was valuable to setup in vitro
model systems (i.e. “external addition” and “pre-incorporation” models)thatmimic both cases. Our current results have shown that the Aβ aggre-
gationpathways for these two systemswere very distinct in terms of both
the ﬁbril structures and the membrane disruption. We were encouraged
that all samples prepared using a single protocol but with different lipid
mixture components showed a uniform trend in ThT and Rh ﬂuorescence
measurements,whichmeans that the in vitromodel is probably robust for
studying the extracellular aggregation of Aβ. However, it was also noticed
that the absolute values of ﬂuorescence emissions are different, which
indicated that the detailed ﬁbril structures are sensitive to membrane
components. Therefore in future tests, it is important to use models
thatmimic the humanbrain environments aroundneurons, and the addi-
tion of human brain extracts without amyloid plaques might be helpful
[34,57].
The solid state NMR results also provide hints to the aggregation
pathway at molecular level. Although the TEM morphologies of the
“external addition” and “pre-incorporation” ﬁbrils were different, their
NMR linewidths for the residues Phe19 and Leu34 look similar. This
means that in both cases, the peptide conformations at the hydrophobic
core regions (i.e. C-terminal and N-terminal β strands) were probably
deﬁned. However, the molecular interaction that stabilizes the tertiary
structure is not established. For instance, the formation of “steric zip-
per”, which has been proposed to be crucial for the amyloid ﬁbril struc-
tures, requires hydrophobic interactions between the side chains of
several pairs of residue [70,71]. In the presence of membrane bilayers,
there might be an energy cost for the formation of such hydrophobic
interactions because the Aβ peptides may initially interact with the
membrane. Such interaction could become stronger if the samples are
prepared in a “pre-incorporation”way. Therefore, certain types of inter-
mediate structures may also be stabilized in the presence of the mem-
brane. In addition, different sample preparation protocols may affect
the amyloidosis pathway because of the difference in local Aβ concen-
tration. Previous CD and 19F solid state NMR studies have demonstrated
the formation of distinct Aβ aggregation intermediates due to the
change in the initial protein concentration [72].
5. Conclusion
Wemonitored the Aβ ﬁbrillation process and the associated mem-
brane disruption using two biologically relevant in vitromodel systems
by TEM,ﬂuorescence spectroscopy and solid state NMR. Our results sug-
gested that the Aβ ﬁbrillation pathways were strongly affected by the
initial states of peptides in membrane systems, i.e. whether the sample
was prepared with the external addition or pre-incorporation of the
peptide. These two models may serve as mimics for the biological sce-
narios of extracellular aggregation of Aβ and formation of endosomes,
respectively. For both of these two model systems, the Aβ peptides
were proved to be non-fusogenic. Membrane disruption was induced
by the initial structural change of the membrane-associated peptides,
and possibly through the mechanisms of phospholipid uptake. Elonga-
tion of mature ﬁbrils may have less effect on the integrity of membrane
bilayers. High resolution studies showed that the long-range contact
that stabilizes the hydrophobic core regions of Aβ ﬁbrils may form
after the local secondary conformation of peptide backbone. Certain in-
termediate structures may be stabilized by the interaction between the
peptides and membrane.
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